Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Pediatrics
Published in: European Journal of Pediatrics 3/2011

01-03-2011 | Review

Educational paper

Screening in cancer predisposition syndromes: guidelines for the general pediatrician

Authors: Alexis Teplick, Megan Kowalski, Jaclyn A. Biegel, Kim E. Nichols

Published in: European Journal of Pediatrics | Issue 3/2011

Login to get access

Abstract

Improvements in our understanding of the genetic basis of human disease and increased utilization of genetic testing have identified a variety of heritable disorders associated with the onset of benign or malignant neoplasms during childhood. In many cases, the optimal management of affected children is dependent upon the early detection and treatment of tumors. Surveillance strategies based on the natural history of these lesions are often complex, requiring clinical examinations and radiologic and laboratory studies that evolve over a patient’s lifetime. A general pediatrician may be the first to suspect one of these disorders in a patient, or may be faced with questions regarding genetic testing, cancer risk, and cancer screening. The pediatrician may also coordinate and interpret the results of specific surveillance studies. In this review, we present the genetic etiology, presentation, natural history, and surveillance recommendations for four disparate hereditary tumor predisposing syndromes, including Beckwith–Wiedemann syndrome/idiopathic hemihyperplasia, von Hippel–Lindau disease, Li–Fraumeni syndrome, and rhabdoid tumor/schwannomatosis. These examples are meant to offer the clinician practical recommendations as well as a framework upon which to base the understanding and management of other conditions associated with an increased risk to develop tumors in childhood.
Literature
1.
Baghai M, Thompson GB, Young WF Jr et al (2002) Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: a role for laparoscopic and cortical-sparing surgery. Arch Surg 137:682–688PubMedCrossRef
2.
Baldisserotto M, Peletti AB, Angelo de Araújo M et al (2005) Beckwith-Wiedemann syndrome and bilateral adrenal pheochromocytoma: sonography and MRI findings. Pediatr Radiol 35:1132–1134PubMedCrossRef
3.
Barlaskar FM, Hammer GD (2007) The molecular genetics of adrenocortical carcinoma. Rev Endocr Metab Disord 8:343–348PubMedCrossRef
4.
Beckwith JB (1998) Children at increased risk for Wilms tumor: monitoring issues. J Pediatr 132:377–379PubMedCrossRef
5.
Bémurat L, Gosse P, Ballanger P et al (2002) Successful lapaproscopic operation of bilateral pheochromocytoma in a patient with Beckwith-Wiedemann syndrome. J Hum Hypertens 16:281–284PubMedCrossRef
6.
Bliek J, Gicquel C, Maas S et al (2004) Epigenotyping as a tool for the prediction of tumor risk and tumor type in patients with Beckwith-Wiedemann syndrome (BWS). J Pediatr 145:796–799PubMedCrossRef
7.
Biegel JA, Zhou J, Rorke LB et al (1999) Germ-line and acquired mutations of INI1 in atypical teratoid rhabdoid tumor. Cancer Res 59:74–79PubMed
8.
Birch JM, Hartley AL, Tricker KJ et al (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li–Fraumeni families. Cancer Res 54:1298–1304PubMed
9.
Birch JM, Alston RD, McNally RJ et al (2001) Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20:4621–4628PubMedCrossRef
10.
Boyd C, Smith MJ, Kluwe L et al (2008) Alterations in the SMARCB1 (INI1) tumor suppressor gene in familial schwannomatosis. Clin Genet 74:358–366PubMedCrossRef
11.
Bruggers CS, Bleyl SB, Pysher T et al (2010) Clincopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer. doi:10.​1002/​pbc.​22757 PubMed
12.
Burgess J (2010) How should the patient with multiple endocrine neoplasia type 1 (MEN 1) be followed? Clin Endocrinol Oxf 72:13–16PubMedCrossRef
13.
Choyke PL, Siegel MJ, Craft AW et al (1999) Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy. Med Pediatr Oncol 32:196–200PubMedCrossRef
14.
Clericuzio CL, Chen E, McNeil DE et al (2003) Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr 143:270–272PubMedCrossRef
15.
Clark PE, Cookson MS (2008) The von Hippel-Lindau gene: turning discovery into therapy. Cancer 113:1768–1778PubMedCrossRef
16.
17.
Cooper WN, Luharia A, Evans GA et al (2005) Molecular subtypes and phenotypic expression of Beckwith-Wiedemann syndrome. Eur J Hum Genet 13:1025–1032PubMedCrossRef
18.
Eaton KW, Tooke LS, Wainwright LM et al (2011) Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 56(1):7–15PubMedCrossRef
19.
Engel JR, Smallwood A, Harper A et al (2000) Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J Med Genet 37:921–926PubMedCrossRef
20.
Evans DG, Lunt P, Clancy T, Eeles R (2010) Childhood predictive genetic testing for Li–Fraumeni syndrome. Fam Cancer 9:65–69PubMedCrossRef
21.
Everman DB, Shuman C, Dzolganovski B et al (2000) Serum alpha-fetoprotein levels in Beckwith-Wiedemann syndrome. J Pediatr 137:123–127PubMedCrossRef
22.
23.
Field M, Shanley S, Kirk J (2007) Inherited cancer susceptibility syndromes in paediatric practice. J Paediatr Child Health 43:219–229PubMedCrossRef
24.
Hilden JM, Meerbaum S, Burger P et al (2004) Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 22:2877–2884PubMedCrossRef
25.
Hisada M, Garber JE, Fung CY et al (1998) Multiple primary cancers in families with Li–Fraumeni syndrome. J Natl Cancer Inst 90:606–611PubMedCrossRef
26.
Hoyme HE, Seaver LH, Jones KL et al (1998) Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review. Am J Med Genet 79:274–278PubMedCrossRef
27.
Hulsebos TJM, Plomp AS, Woterman RA et al (2007) Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 80:805–810PubMedCrossRef
28.
Hwang SJ, Lozano G, Amos CI, Strong LC (2003) Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk. Am J Hum Genet 72:975–983PubMedCrossRef
29.
Jackson EM, Shaikh TH, Zhang F et al (2007) Atypical teratoid/rhabdoid tumor in a patient with Beckwith-Wiedemann syndrome. Am J Med Genet A 143A:1767–1770PubMedCrossRef
30.
Kaatsch P, Steliarova-Foucher E, Crocetti E et al (2006) Time trends of cancer incidence in European children (1978–1997): report from the automated childhood cancer information system project. Eur J Cancer 42:1961–1971PubMedCrossRef
31.
Katzenstein HM, London WB, Douglass E et al (2002) Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study. J Clin Oncol 20:3438–3444PubMedCrossRef
32.
Kim HJ, Butman JA, Brewer C et al (2005) Tumors of the endolymphatic sac in patients with von Hippel-Lindau disease: implications for their natural history, diagnosis and treatment. J Neurosurg 102:503–512PubMedCrossRef
33.
Lapunzina P (2005) Risk of tumorigenesis in overgrowth syndromes: a comprehensive review. Am J Med Genet 137C:53–71PubMedCrossRef
34.
Lammens CRM, Aaronson NK, Wagner A et al (2010) Genetic testing in Li–Fraumeni Syndrome: uptake and psychosocial consequences. J Clin Oncol 28:3008–3014PubMedCrossRef
35.
Lammens CRM, Bleiker EMA, Aaronson NK et al (2010) Regular surveillance for Li–Fraumeni syndrome: advice, adherence and perceived benefits. Fam Cancer 9(4):647–654PubMedCrossRef
36.
37.
38.
MacCollin M, Chiocca EA, Evans DG et al (2005) Diagnostic criteria for schwannomatosis. Neurology 64:1838–1845PubMedCrossRef
39.
Maher ER, Yates JR, Harries R et al (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151–1163PubMed
40.
Manksi TJ, Heffner DK, Glenn GM et al (1997) Endolymphatic sac tumors: a source of morbid hearing loss in von Hippel-Lindau disease. JAMA 277:1461–1466CrossRef
41.
Masciari S, Van den Abbeele AD, Diller LR (2008) F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li–Fraumeni syndrome. JAMA 299:1315–1319PubMedCrossRef
42.
Meister M, Choyke P, Anderson C, Patel U (2009) Radiological evaluation, management and surveillance of renal masses in Von Hippel-Lindau disease. Clin Radiol 64:589–600PubMedCrossRef
43.
Moule RN, Jhavar SG, Eeles RA (2006) Genotype phenotype correlation in Li–Fraumeni syndrome kindreds and its implications for management. Fam Cancer 5:129–133PubMedCrossRef
44.
NCCN (2008) The NCCN Clinical Practice Guidelines in Oncology™ Li–Fraumeni syndrome (Version 1.2008). © 2009 National Comprehensive Cancer Network, Inc. www.​nccn.​org. Accessed March 15, 2009. To view the most recent and complete version of the NCCN Guidelines, login to http://​www.​nccn.​org
45.
Neumann HP, Bender BU, Berger DP et al (1998) Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 160:1248–1254PubMedCrossRef
46.
Oda Y, Tsuneyoshi M (2006) Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features. Pathol Int 56:287–295PubMedCrossRef
47.
Olivier M, Goldgar DE, Sodha N et al (2003) Li–Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 63:6643–6650PubMed
48.
Perilongo G, Shafford E, Maibach R (2004) Risk-adapted treatment for childhood hepatoblastoma. Final report of the second study of the International Society of Paediatric Oncology—SIOPEL 2. Eur J Cancer 40:411–421PubMedCrossRef
49.
Poulsen MLM, Budtz-Jørgensen E, Bisgaard ML (2010) Surveillance in von Hippel-Lindau disease (vHL). Clin Genet 77:49–59PubMedCrossRef
50.
Porteus MH, Narkool P, Neuberg D et al (2000) Characteristics and outcome of children with Beckwith-Wiedemann syndrome and Wilms' tumor: a report from the national Wilms tumor study group. J Clin Oncol 18:2026–2031PubMed
51.
Priesemann M, Davies KM, Perry LA et al (2006) Benefits of screening in von Hippel-Lindau disease—comparison of morbidity associated with initial tumours in affected parents and children. Horm Res 66:1–5PubMedCrossRef
52.
Proust F, Laquerriere A, Constantin B et al (1999) Simultaneous presentation of atypical teratoid/rhabdoid tumor in siblings. J Neuroncol 43:63–70CrossRef
53.
Rao A, Rothman J, Nichols KE (2008) Genetic testing and tumor surveillance for children with cancer predisposition syndromes. Curr Opin Pediatr 20:1–7PubMedCrossRef
54.
55.
Ries LAG, Smith MA, Gurney JG et al. editors (1999) Cancer incidence and survival among children and adolescents: United States SEER Program 1975–1995. Bethesda (MD): National Cancer Institute, SEER Program NIH Pub. No. 99–4649
56.
Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65PubMedCrossRef
57.
58.
Sévenet N, Sheridan E, Amram D et al (1999) Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancer. Am J Hum Genet 65:1342–1348PubMedCrossRef
59.
Slavin TP, Wiesner GL (2009) Developmental defects and childhood cancer. Curr Opin Pediatr 21:717–723PubMedCrossRef
60.
Strahm B, Malkin D (2006) Hereditary cancer predisposition in children: genetic basis and clinical implications. Int J Cancer 119:2001–2006PubMedCrossRef
61.
Swensen JJ, Keyser J, Coffin CM et al (2009) Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1. J Med Genet 46:68–72PubMedCrossRef
62.
Tabori U, Malkin D (2008) Risk stratification in cancer predisposition syndromes: lessons learned from novel molecular developments in Li–Fraumeni syndrome. Cancer Res 68:2053–2057PubMedCrossRef
63.
Tan TY, Amor DJ (2006) Tumour surveillance in Beckwith-Wiedemann syndrome and hemihyperplasia: a critical review of the evidence and suggested guidelines for local practice. J Paediatr Child Health 42:486–490PubMedCrossRef
64.
Tomlinson GE, Breslow NE, Dome J et al (2005) Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. J Clin Oncol 23:7641–7645PubMedCrossRef
65.
66.
Vousden KH, Prives C (2009) Blinded by the light: The growing complexity of p53. Cell 137:413–431PubMedCrossRef
67.
Weksberg R, Nishikawa J, Caluseriu O et al (2001) Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet 10:2989–3000PubMedCrossRef
68.
69.
70.
Zarate YA, Mena R, Martin LJ et al (2009) Experience with hemihyperplasia and Beckwith–Wiedemann syndrome surveillance protocol. Am J Med Genet 149A:1691–1697PubMedCrossRef
Metadata
Title
Educational paper
Screening in cancer predisposition syndromes: guidelines for the general pediatrician
Authors
Alexis Teplick
Megan Kowalski
Jaclyn A. Biegel
Kim E. Nichols
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 3/2011
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-010-1377-2

Other articles of this Issue 3/2011

European Journal of Pediatrics 3/2011 Go to the issue

Acknowledgement to our Reviewers

ACKNOWLEDGEMENTS

Short Report

Household poisoning cases from mercury brought from school

Review

Poor adherence to antibiotic prescribing guidelines in acute otitis media—obstacles, implications, and possible solutions

Review

Position paper—HPV and the primary prevention of cancer; improving vaccine uptake by paediatricians

Original Paper

Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital

Original Paper

Parental reports of adverse events following simultaneously given dT-IPV and MMR vaccines in healthy 9-year-old children